Caption Management
SUPN icon

Caption Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Caption Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-45,000
Closed -$2.33M – 2031
2026
Q1 		$2.33M Sell
45,000
-12,700
-22% -$647K 0.01% 783
2025
Q4 		$2.87M Buy
+57,700
New +$2.81M 0.02% 703
2024
Q3 		– Sell
-20,000
Closed -$535K – 1583
2024
Q2 		$535K Hold
20,000
– – 0.01% 797
2024
Q1 		$682K Buy
+20,000
New +$595K 0.01% 821
2022
Q2 		– Sell
-50,000
Closed -$1.62M – 1815
2022
Q1 		$1.62M Buy
+50,000
New +$1.53M 0.02% 827
2019
Q1 		– Sell
-15,000
Closed -$499K – 719
2018
Q4 		$499K Buy
+15,000
New +$645K 0.04% 334

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Nomura Asset Management International
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Stephens Investment Management Group
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Caption Management's SUPN Position: Q4 2025 in Review

Caption Management sold out of Supernus Pharmaceuticals (SUPN) in Q4 2025, closing a stake of 28,341 shares — an estimated $1.38M sold.

Caption Management first reported a position in SUPN in Q4 2018 and held it in 5 quarters. The position peaked at $1.46M in Q4 2020. 335 funds tracked by Wall St. Rank hold SUPN as of Q4 2025.

  • Caption Management reported no remaining Supernus Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Caption Management sold 28,341 Supernus Pharmaceuticals shares in Q4 2025, an estimated $1.38M.
  • Caption Management first reported a position in Supernus Pharmaceuticals in Q4 2018 and held it in 5 quarters.
  • Caption Management's Supernus Pharmaceuticals position peaked at $1.46M in Q4 2020.
  • 335 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q4 2025.

Based on Caption Management's 13F filing for Q4 2025, filed 17 Feb 2026.